Education
About Us
Working with TipRanks
Follow Us
Sera Prognostics, Inc. (SERA)
:SERA
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.25Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: -20.00%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced outlook. While there are positive developments in Medicaid reimbursement and strategic headcount expansion, the company's revenue generation remains minimal, and net losses continue. The ACOG update aligns with the company's strategy, but uncertainties around the Prime Study publication timeline persist.Company Guidance
During Sera Prognostics' first quarter fiscal year 2025 earnings call, the company provided guidance focusing on its commercial growth strategy following the release of pivotal PRIME study results. The company reported a net revenue of $38,000 for the quarter, with total operating expenses of $9.3 million, slightly up from $9.1 million the previous year. The net loss for the quarter was $8.2 million, stable compared to the prior year. Sera Prognostics highlighted its reimbursement strategy, targeting commercial insurance, employers, and Medicaid, which covers about 43% of U.S. births. The company aims to expand its sales force by 5-10 FCEs and is pursuing Medicaid plan pilots in states with high premature birth rates, anticipating the closure of some pilots within months. With $114.2 million in cash and equivalents as of March 31, 2025, Sera Prognostics is selectively deploying capital to drive test adoption and increase revenue, emphasizing tailored care based on risk stratification highlighted by recent ACOG recommendations.Progress in Medicaid Reimbursement
Sera Prognostics is ramping up Medicaid plan pilots in states most impacted by premature births, aiming to close promising pilots for managed Medicaid plans within months.
Strategic Headcount Expansion
The company plans to expand its commercial presence by 5 to 10 full-time equivalent employees (FCEs) to resource targeted states and enhance commercial opportunities.
ACOG Bulletin Update
The American College of Obstetricians and Gynecologists (ACOG) released an updated clinical consensus emphasizing risk assessments in prenatal care, aligning with Sera Prognostics' PreTRM test strategy.
Increased Revenue
Net revenue for the first quarter of 2025 was $38,000, compared to nil for the first quarter of 2024.
Strong Cash Position
As of March 31, 2025, the company had cash, cash equivalents, and available-for-sale securities of approximately $114.2 million.
SERA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SERA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $2.40 | $2.12 | -11.67% |
Mar 19, 2025 | $4.14 | $3.93 | -5.07% |
Nov 06, 2024 | $8.74 | $7.63 | -12.70% |
Aug 07, 2024 | $7.40 | $7.41 | +0.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sera Prognostics, Inc. (SERA) report earnings?
Sera Prognostics, Inc. (SERA) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Sera Prognostics, Inc. (SERA) earnings time?
Sera Prognostics, Inc. (SERA) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SERA EPS forecast?
SERA EPS forecast for the fiscal quarter 2025 (Q2) is -0.23.